DAMORA THERAPEUTICS, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
DAMORA THERAPEUTICS, INC. (DMRA) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$205.93 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-19
- DAMORA THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$205.93M.
- DAMORA THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$11.39M.
- DAMORA THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$8.14M.
- DAMORA THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$10.16M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$205.93M 10-K · filed 2026-03-19 |
| 2024-12-31 | -$11.39M 10-K · filed 2026-03-19 |
| 2023-12-31 | -$8.14M 10-K · filed 2025-03-19 |
| 2022-12-31 | -$10.16M 10-K · filed 2024-03-08 |
| 2021-12-31 | -$11.25M 10-K · filed 2023-03-09 |
| 2020-12-31 | -$7.54M 10-K · filed 2022-02-17 |
| 2019-12-31 | -$16.79M 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |